ARTICLE | Clinical News
Tacrolimus: Phase II data
January 10, 2011 8:00 AM UTC
Top-line data from an open-label Phase II trial in 58 patients showed that once-daily LCP-Tacro tablets demonstrated comparable tolerability to twice-daily Prograf tacrolimus capsules over 1 year. Th...